Fresenius Medical Care Corporation (FMS)vsOncology Institute Inc (TOI)
FMS
Fresenius Medical Care Corporation
$22.26
+1.04%
HEALTHCARE · Cap: $12.47B
TOI
Oncology Institute Inc
$3.13
-2.49%
HEALTHCARE · Cap: $288.00M
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 4525% more annual revenue ($19.63B vs $424.38M). FMS leads profitability with a 5.0% profit margin vs -15.5%. FMS earns a higher WallStSmart Score of 62/100 (C+).
FMS
Buy62
out of 100
Grade: C+
TOI
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.26
$68.06 discount
Intrinsic value data unavailable for TOI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Conservative balance sheet, low leverage
Revenue surging 21.5% year-over-year
Areas to Watch
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -6.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bull Case : TOI
The strongest argument for TOI centers on Debt/Equity, Revenue Growth. Revenue growth of 21.5% demonstrates continued momentum.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Bear Case : TOI
The primary concerns for TOI are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
FMS profiles as a value stock while TOI is a growth play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.94 — expect wider price swings.
TOI is growing revenue faster at 21.5% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 42/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Oncology Institute Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Oncology Institute Inc (ticker: TOI) is a leading healthcare organization committed to revolutionizing cancer care through its expansive network of specialized clinics and advanced treatment options. Focused on improving patient outcomes, the company utilizes cutting-edge technologies and tailored treatment strategies, while actively engaging in clinical trials and partnerships with esteemed research institutions. As the demand for innovative cancer therapies accelerates, TOI is well-positioned to capitalize on its extensive pipeline and deep oncology expertise, solidifying its role as a vital participant in the dynamic healthcare landscape.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?